Jonathan O'Brien (Cork North Central, Sinn Fein) | Oireachtas source

I wish to tease out that point. It was interesting that earlier we were saying that the clinical evidence must reach a certain level. There is a possibility that the clinical evidence might not be published or contained in peer-reviewed journals before the HPRA's review is completed. There could be a scenario where there is a recommendation that we should pursue a new legal policy or framework to provide medicinal cannabis in the future without the clinical reviews being published. Would the witnesses see that as a barrier to any recommendations they might be examining or would they be of the same opinion as Dr. Doherty? If there is policy advice to the Minister that this is something we can provide within the existing framework while we are waiting for a new legal framework to be completed, does Dr. Doherty think that would satisfy physicians in terms of prescribing or would there still be hesitation until it reached that clinical point?